Treatment.com International ( (TSE:TRUE) ) has shared an announcement.
Treatment.com AI Inc. has announced a definitive agreement to acquire Rocket Doctor Inc., a digital health company that empowers doctors to establish virtual practices in the U.S. and Canada. This acquisition will enhance Treatment.com’s capabilities by integrating Rocket Doctor’s AI-powered platform, boosting the network to over 300 doctors and increasing services billable value to C$7.1 million. The deal, valued at approximately C$11 million in shares with potential additional consideration based on performance, aims to drive innovation in digital healthcare services across North America, offering a proof of concept for future commercial sales of Treatment’s software.
More about Treatment.com International
Treatment.com AI Inc. operates in the digital health industry, focusing on innovative healthcare solutions. The company develops AI-powered platforms to enhance medical practices and patient care, leveraging a Global Library of Medicine to support healthcare professionals.
YTD Price Performance: 12.42%
Average Trading Volume: 5,405
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $18.86M
Learn more about TRUE stock on TipRanks’ Stock Analysis page.